Thermo Fisher Scientific Balance Sheet Health
Financial Health criteria checks 3/6
Thermo Fisher Scientific has a total shareholder equity of $46.8B and total debt of $35.0B, which brings its debt-to-equity ratio to 74.7%. Its total assets and total liabilities are $98.7B and $51.9B respectively. Thermo Fisher Scientific's EBIT is $7.4B making its interest coverage ratio 14.9. It has cash and short-term investments of $8.1B.
Key information
74.7%
Debt to equity ratio
US$35.01b
Debt
| Interest coverage ratio | 14.9x |
| Cash | US$8.08b |
| Equity | US$46.84b |
| Total liabilities | US$51.88b |
| Total assets | US$98.73b |
Recent financial health updates
We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Mar 12
Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?
Dec 11Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Sep 10These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well
Jun 07Recent updates
Thermo Fisher Scientific: Too Hot To Handle
Apr 15Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)
Apr 02We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Mar 12Thermo Fisher's Bright Future Makes It A Great Buy On Weakness
Feb 06Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results
Feb 02Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics
Jan 16Thermo Fisher: Downturn In Pharma And Biotech And Weak China Growth; Initiate With 'Hold'
Jan 06Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?
Dec 29Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?
Dec 11Thermo Fisher Scientific: I Am Still Waiting For An Attractive Buying Opportunity.
Dec 02Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate
Nov 07My Family Is Buying A Lot More Thermo Fisher Stock
Oct 31Thermo Fisher: An Up To 35% Undervalued Healthcare Gem I Like On Weakness
Sep 28Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Sep 10Thermo Fisher Scientific: A High-Quality Investment For Double-Digit Returns
Aug 28Thermo Fisher: Cash Flow Returns On Investments Analysis
Aug 14Calculating The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)
Jul 25Thermo Fisher Scientific: Continuing To Add To The Fortress
Jul 09Thermo Fisher: A Master Compounder In Healthcare
Jul 03These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well
Jun 07Buy Thermo Fisher, But With Caution
Jun 01Thermo Fisher Scientific Inc.'s (NYSE:TMO) Intrinsic Value Is Potentially 25% Below Its Share Price
Apr 26Financial Position Analysis
Short Term Liabilities: TMO's short term assets ($24.6B) exceed its short term liabilities ($14.0B).
Long Term Liabilities: TMO's short term assets ($24.6B) do not cover its long term liabilities ($37.9B).
Debt to Equity History and Analysis
Debt Level: TMO's net debt to equity ratio (57.5%) is considered high.
Reducing Debt: TMO's debt to equity ratio has increased from 69.3% to 74.7% over the past 5 years.
Debt Coverage: TMO's debt is well covered by operating cash flow (24%).
Interest Coverage: TMO's interest payments on its debt are well covered by EBIT (14.9x coverage).